KOREA WHO
-
-
-
CEO of Daewoong Pharmaceutical
Lee Chang-jae
Innovation-Driven Sales and Marketing Leader Steering Digital Healthcare
-
Last Updated on Feb 5, 2026
-
CEO of Daewoong Pharmaceutical
Life Summary
Lee Chang-jae is the CEO of Daewoong Pharmaceutical.
He leads Daewoong Pharmaceutical under a co-CEO system with CEO Park Sung-soo.
He aims to go beyond treating diseases with medicines and transform the company into a global healthcare company that connects and manages health data for the entire population.
He was born in June 1977.
He graduated from Busan High School and the Department of Chinese Language and Literature at Dong-A University.
After joining Daewoong Pharmaceutical, he was promoted in his early 40s to become the company’s youngest-ever marketing executive as Head of the Marketing Division. He later served as Head of Human Resources and Management, Head of the ETC Division, and Executive Vice President overseeing marketing and sales.
In 2021, he was appointed CEO of Daewoong Pharmaceutical. He was reappointed in 2024.
He places strong emphasis on the happiness of employees and has introduced innovations in the way people work.
He believes that meaningful results are achieved only when employees develop a strong sense of ownership and move forward toward ambitious goals.
He also serves concurrently as CEO of affiliate DanaData.
He leads Daewoong Pharmaceutical under a co-CEO system with CEO Park Sung-soo.
He aims to go beyond treating diseases with medicines and transform the company into a global healthcare company that connects and manages health data for the entire population.
He was born in June 1977.
He graduated from Busan High School and the Department of Chinese Language and Literature at Dong-A University.
After joining Daewoong Pharmaceutical, he was promoted in his early 40s to become the company’s youngest-ever marketing executive as Head of the Marketing Division. He later served as Head of Human Resources and Management, Head of the ETC Division, and Executive Vice President overseeing marketing and sales.
In 2021, he was appointed CEO of Daewoong Pharmaceutical. He was reappointed in 2024.
He places strong emphasis on the happiness of employees and has introduced innovations in the way people work.
He believes that meaningful results are achieved only when employees develop a strong sense of ownership and move forward toward ambitious goals.
He also serves concurrently as CEO of affiliate DanaData.